Received Feb 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | M4B34 | IM / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | XN575 | LA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 334t3 | IM / RA |
Patient was administered Twinrix, Shingrix, Boostrix on same day 2/9/25. Patient's husband states a rash appeared on patient's stomach and back. The rash wrapped around stomach and backside like a belt. Rash appeared red with raised red bumps and itchy. Patient was referred to primary care provider for evaluation. Patient was seen by telehealth provider to determine cause of rash. Provider instructed patient to take Benadryl to alleviate itch and increased dosage of Valtrex due to suspected shingles rash from immunization. Provider did not provide clear diagnosis/cause of rash per patient's husband. The rash has improved over the course of 2 weeks and has cleared.
Latex, sulfa drugs